NASDAQ:KTTA

Pasithea Therapeutics Stock Forecast

etoro logo Buy KTTA
*Your capital is at risk
$0.526
-0.0173 (-3.18%)
At Close: Jun 29, 2026
AI Analysis AI Analysis of KTTA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add KTTA to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Pasithea Therapeutics Corp. stock price on Monday moving 13.13% between high and low
(Updated on Jun 29, 2026)

Sell candidate since May 15, 2026 Loss -32.56%

The Pasithea Therapeutics Corp. stock price fell by -3.18% on the last day (Monday, 29th Jun 2026) from $0.543 to $0.526. During the last trading day the stock fluctuated 13.13% from a day low at $0.513 to a day high of $0.580. The price has fallen in 7 of the last 10 days and is down by -11% for this period. Volume has increased on the last day by 174 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 406 thousand shares were bought and sold for approximately $213.76 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.21% during the next 3 months and, with a 90% probability hold a price between $0.357 and $0.529 at the end of this 3-month period.

KTTA Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 5.22%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Pasithea Therapeutics Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.539 and $0.646. A break-up above any of these levels will issue buy signals. Pasithea Therapeutics Corp. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Pasithea Therapeutics Corp. stock

Pasithea Therapeutics Corp. finds support from accumulated volume at $0.510 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0673 between high and low, or 13.13%. For the last week, the stock has had daily average volatility of 10.72%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KTTA) For The Upcoming Trading Day Of Tuesday 30th

For the upcoming trading day on Tuesday, 30th we expect Pasithea Therapeutics Corp. to open at $0.540, and during the day (based on 14 day Average True Range), to move between $0.500 and $0.552, which gives a possible trading interval of +/-$0.0522 (+/-10.45%) up or down from last closing price. If Pasithea Therapeutics Corp. takes out the full calculated possible swing range there will be an estimated 10.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.539 (2.43%) than the support at $0.510 (3.06%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Pasithea Therapeutics Corp. stock A Buy?

Pasithea Therapeutics Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.080 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 30, 2026 - $0.540 ( 2.55%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

KTTA Performance

Trading levels for KTTA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.607 15.35%
R2 0.581 10.46%
R1 0.565 7.44%
Price 0.526
S1 0.514 -2.33%
S2 0.498 -5.35%
S3 0.472 -10.24%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.645 22.60%
R2 0.560 6.44%
R1 0.539 2.43%
Price 0.526
S1 0.510 -3.06%
S2 0.502 -4.52%
S3 0.500 -4.96%

FAQ

What is the symbol for Pasithea Therapeutics Corp. Stock and on which exchange is it traded?
The symbol for Pasithea Therapeutics Corp. is KTTA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pasithea Therapeutics Corp. Stock?
Pasithea Therapeutics Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Pasithea Therapeutics Corp. Stock?
Pasithea Therapeutics Corp. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pasithea Therapeutics Corp. Stock.

What's the current price of Pasithea Therapeutics Corp. Stock?
As of the end of day on the Jun 29, 2026, the price of an Pasithea Therapeutics Corp. (KTTA) share was $0.526.

What is the 52-week high and low for Pasithea Therapeutics Corp. Stock?
The 52-week high for Pasithea Therapeutics Corp. Stock is $2.06 and the 52-week low is $0.281.

What is the market capitalization of Pasithea Therapeutics Corp. Stock?
As of the Jun 29, 2026, the market capitalization of Pasithea Therapeutics Corp. is 3.915M.

When is the next earnings date for Pasithea Therapeutics Corp.?
The upcoming earnings date for Pasithea Therapeutics Corp. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT PASITHEA THERAPEUTICS CORP.
Pasithea Therapeutics
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida....
GOLDEN STAR
Ticker Change Signal Date
IIIV
$20.09
5.03% Jun 25
X
XMAX
$8.34
7.31% Jun 24
NMRK
$15.02
1.60% Jun 24
JLL
$299.78
4.44% Jun 24
CAG
$13.43
4.06% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE